- Home
- ZURA vs KIDS Comparison
ZURA vs KIDS Comparison
Compare ZURA & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZURA | KIDS |
|---|---|---|
| Founded | 2022 | 2007 |
| Country | United States | United States |
| Employees | 40 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.4M | 512.4M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | ZURA | KIDS |
|---|---|---|
| Price | $5.23 | $18.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | $13.00 | ★ $24.67 |
| AVG Volume (30 Days) | ★ 1.5M | 158.9K |
| Earning Date | 05-14-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $98,049,000.00 |
| Revenue This Year | N/A | $14.07 |
| Revenue Next Year | N/A | $11.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 37.95 |
| 52 Week Low | $1.35 | $14.42 |
| 52 Week High | $7.25 | $23.07 |
Technical Indicators
Market Signals| Indicator | ZURA | KIDS |
|---|---|---|
| Relative Strength Index (RSI) | 52.35 | 45.32 |
| Support Level | $5.17 | $15.66 |
| Resistance Level | $5.88 | $18.75 |
| Average True Range (ATR) | 0.40 | 1.13 |
| MACD | -0.03 | -0.22 |
| Stochastic Oscillator | 40.12 | 18.17 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.